Cita APA

Krendyukov, A., Kneisel, N., Zhu, J., Merz, C., Richards, D., Gieffers, C., . . . Mitchell, T. (2020). The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model. Elsevier.

Citación estilo Chicago

Krendyukov, A., N. Kneisel, J. Zhu, C. Merz, D. Richards, C. Gieffers, B. Van Den Eynde, and T. Mitchell. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.

Cita MLA

Krendyukov, A., et al. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.